Gene · 8764
Papers3,537
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
961 to 980 of 3,537
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Dendritic Cells: The Long and Evolving Road towards Successful Targetability in Cancer. | Cells | 2022 | 36230990 | PubTator, text mining | PubMed |
| Single-cell sequencing of PBMC characterizes the altered transcriptomic landscape of classical monocytes in BNT162b2-induced myocarditis. | Front Immunol | 2022 | 36225942 | PubTator, text mining | PubMed |
| Leucine zipper protein 2 serves as a prognostic biomarker for prostate cancer correlating with immune infiltration and epigenetic regulation. | Heliyon | 2022 | 36217461 | PubTator, text mining | PubMed |
| Prediction of hepatocellular carcinoma prognosis and immunotherapeutic effects based on tryptophan metabolism-related genes. | Cancer Cell Int | 2022 | 36217206 | PubTator, text mining | PubMed |
| Role of ARRB1 in prognosis and immunotherapy: A Pan-Cancer analysis. | Front Mol Biosci | 2022 | 36213111 | PubTator, text mining | PubMed |
| Cuproptosis-related lncRNAs predict the clinical outcome and immune characteristics of hepatocellular carcinoma. | Front Genet | 2022 | 36212138 | PubTator, text mining | PubMed |
| Prognostic value of TIGIT in East Asian patients with solid cancers: A systematic review, meta-analysis and pancancer analysis. | Front Immunol | 2022 | 36211383 | PubTator, text mining | PubMed |
| Revealing the characteristics of ZIKV infection through tissue-specific transcriptome sequencing analysis. | BMC Genomics | 2022 | 36209057 | PubTator, text mining | PubMed |
| Glycosyltransferase-related long non-coding RNA signature predicts the prognosis of colon adenocarcinoma. | Front Oncol | 2022 | 36203430 | PubTator, text mining | PubMed |
| Pan-Cancer Gene Analysis of m6A Modification and Immune Infiltration in Uterine Corpus Endometrial Carcinoma. | Comput Intell Neurosci | 2022 | 36199963 | PubTator, text mining | PubMed |
| The Systematic Analyses of RING Finger Gene Signature for Predicting the Prognosis of Patients with Hepatocellular Carcinoma. | J Oncol | 2022 | 36199791 | PubTator, text mining | PubMed |
| Single-cell dissection of remodeled inflammatory ecosystem in primary and metastatic gallbladder carcinoma. | Cell Discov | 2022 | 36198671 | PubTator, text mining | PubMed |
| Adenosine signaling: Optimal target for gastric cancer immunotherapy. | Front Immunol | 2022 | 36189223 | PubTator, text mining | PubMed |
| Development of immunotherapy for high-grade gliomas: Overcoming the immunosuppressive tumor microenvironment. | Front Med (Lausanne) | 2022 | 36186781 | PubTator, text mining | PubMed |
| Single-cell transcriptome profiling of the human endometrium of patients with recurrent implantation failure. | Theranostics | 2022 | 36185612 | PubTator, text mining | PubMed |
| Identification and validation of a novel necroptosis-related prognostic signature in cervical squamous cell carcinoma and endocervical adenocarcinoma. | Front Oncol | 2022 | 36185274 | PubTator, text mining | PubMed |
Integrated TCR repertoire analysis and single-cell transcriptomic profiling of tumor-infiltrating T cells in renal cell carcinoma identifies shared and tumor-restricted expanded clones with unique phenotypes. | Front Oncol | 2022 | 36185254 | PubTator, text mining | PubMed |
| Single cell sequencing analysis and transcriptome analysis constructed the liquid-liquid phase separation(LLPS)-related prognostic model for endometrial cancer. | Front Oncol | 2022 | 36185238 | PubTator, text mining | PubMed |
| FAIM2 is a potential pan-cancer biomarker for prognosis and immune infiltration. | Front Oncol | 2022 | 36185230 | PubTator, text mining | PubMed |
| Overcoming the cardiac toxicities of cancer therapy immune checkpoint inhibitors. | Front Oncol | 2022 | 36185227 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8764/papers?page=49